The available database comprises research projects in Fisheries, Aquaculture, Seafood Processing and Marine Biotechnology active in the time period 2003-2022.
BlueBio is an ERA-NET COFUND created to directly identify new and improve existing ways of bringing bio-based products and services to the market and find new ways of creating value from in the blue bioeconomy.

More information on the BlueBio project and participating funding organizations is available on the BlueBio website: www.bluebioeconomy.eu

Last Update: 2024/06/19

REM-AQUA
Aquaculture
Marine Biotechnology
Remediation of aquaculture effluents through degradation using photosensitizers
Nat. Programme (supported by ESIF)
National-European
Diana Luísa Duarte de Lima
NA
CESAM - Centre for Environmental and Marine Studies (Portugal)
NA
2018
2021
€ 217,833
https://www.cesam-la.pt/projetos/rem-aqua-remediacao-de-efluentes-de-aquacultura-atraves-da-degradacao-com-recurso-a-fotosensibilizadores/
Aquaculture has developed strongly in recent decades, giving rise to highly sophisticated fish farms, making considerable use of feed, hormones and antibiotics, with a recognised environmental impact. To ensure the economic sustainability of the sector, production has been intensified using water recirculation systems and appropriate treatments to optimize the use of this valuable resource that is water. Public health concerns related to the use of antibiotics have encouraged the emergence of strict standards controlling their use, leading to only a few being authorised in aquaculture. Of the anesthetics, only tricaine is authorized by the Food and Drug Administration. The World Health Organization warns of the misuse of antimicrobial drugs and the fact that new resistance mechanisms are "rendering the latest generation of antibiotics virtually ineffective." To the best of our knowledge, the removal of pharmaceuticals from aquaculture effluents has not yet been tested. Photodegradation is an important mechanism in the degradation of compounds, containing, inter alia, aromatic rings or photoactive functional groups, as is the case with most drugs. The photosensitizers (which can be the drugs themselves or other species) absorb the light transferring it to the dissolved oxygen or to another substrate of the medium generating reactive oxygen species (ROS), or in the case of salt water can promote the formation of reactive halogen species (RHS), responsible for the degradation of the target compounds. This project focuses on the development of a "green" technology for water treatment, aiming at photodegradation with solar radiation, through the production of ROS originated under irradiation, of drugs used in aquacultures. Photocatalysts, such as carbon nanomaterials, carbon dots, will be synthesized and tested as photosensitizers, as they have been reported as promising in increasing the rate of photodegradation and in the complete removal of drugs from wastewater, due to their low cost and moderate reaction conditions. Knowledge of photodegradation products is essential, not only for academic reasons, but also for their biological properties. The identification of these main products through mass spectrometry techniques, as well as the evaluation of their antibacterial activity and toxicity will be goals to be achieved in this project. This project is part of Horizon 2020, the European Union's largest ever Research and Innovation programme, which includes the need to optimise and boost marine biotechnologies to foster "blue" growth. It is a multidisciplinary project, encompassing environmental chemistry, biology and organic/inorganic chemistry. Collaboration with the aquaculture industry through SEA8 will be extremely important and will allow access to its effluents.
Land-based aquaculture; Fish; Recirculating systems; Technology; Wastes; Waste water;
NA
map png
If there is any incorrect or missing information on this project please access here or contact bluebio.database@irbim.cnr.it
/* */